Pseudophakic patients may benefit from a fluocinolone acetonide intravitreal implant (Iluvien, Alimera
Sciences), the company tells a United Kingdom committee.
Author: ModernMedecine
Cellular-scale retinal camera receives CE mark
A cellular-level adaptive optics retinal camera (rtx1, Imagine Eyes) has received CE mark approval in
the European Union.
New data confirm efficacy, safety of ranibizumab
New data presented at the European Society of Retina Specialists meeting suggest that ranibizumab is
effective in patients with AMD, DME, and RVO.
Editor’s Blog: Ophthalmologists from around the world come to learn
Mark Dlugoss, Ophthalmology Times editor-in-chief, is blogging daily from ESCRS. Today he discusses
the attendance of Latin American physicians at ESCRS.
Editor’s Blog: Ophthalmologists from around the world come to learn
Mark Dlugoss, Ophthalmology Times editor-in-chief, is blogging daily from ESCRS. Today he discusses
the attendance of Latin American physicians at ESCRS.
STAAR Surgical announces management additions, promotions
The company promotes two and adds another employee as it names three vice presidents.
Sealant being studied for clear corneal wound closure
A new sealant (ReSure, Ocular Therapeutix) will be studied for clear corneal incision closure after
cataract extraction or IOL placement.
New drug delivery system aims to increase tissue penetration
Improved efficacy and dosing convenience are the aims of a new drug delivery system incorporating a
cationic polymer and formulated with ketorolac.
Dry eye: PRK or LASIK?
Before performing refractive surgery, ophthalmologists must recognize the signs of dry eye syndrome
and choose either PRK or LASIK accordingly.
Encourage patients with bilateral vision loss to be more active
Newly published research gives ophthalmologists a reason to encourage their adult patients with visual
field loss in both eyes to be more physically active.
Editor’s Blog: The year of intraocular lenses (IOLs)
Ophthalmology Times editor-in-chief, Mark Dlugoss, is blogging daily from ESCRS. Today he discusses
various releases of intraocular lenses (IOLs).
VA low-vision rehab program yields long-lasting benefits: study
NEW YORK (Reuters Health) – A group of US veterans with moderate to severe visual impairment due to
macular disease are still seeing better one year after participating in the Low-Vision Intervention Trial
(LOVIT).
Editor’s Blog: The year of intraocular lenses (IOLs)
Ophthalmology Times editor-in-chief, Mark Dlugoss, is blogging daily from ESCRS. Today he discusses
various releases of intraocular lenses (IOLs).
Editor’s Blog: ESCRS grown to become a unique ophthalmic meeting
Ophthalmology Times Editor-in-Chief, Mark Dlugoss, blogs daily from the 2012 congress of the European
Society of Cataract and Refractive Surgeons (ESCRS).
Editor’s Blog: ESCRS grown to become a unique ophthalmic meeting
Ophthalmology Times Editor-in-Chief, Mark Dlugoss, blogs daily from the 2012 congress of the European
Society of Cataract and Refractive Surgeons (ESCRS).
Trifocal diffractive intraocular lens reduces spectacle dependency
A trifocal diffractive intraocular lens (FineVision IOL, PhysIOL) reduces spectacle dependence after
cataract surgery and provides patient satisfaction.
Moore named Iridex interim president, CEO
William M. Moore has been named interim president and chief executive officer of Iridex Corp. Moore
succeeds Dominik Beck.
Cause of cone death discovered in retinitis pigmentosa
Researchers have identified the mode of death of cone photoreceptor cells in an animal model of
retinitis pigments (RP).
Glaucoma may be linked to depression
Glaucoma may be a significant predictor of depression, according to research published in the American
Journal of Ophthalmology.
FDA clears laser for cataract surgery incisions
The FDA approved OptiMedica’s Catalys Precision for creating single-plane and multi-plane arc
incisions in the cornea during cataract surgery.